Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Positive Technologies shareholders re-approved the additional share issue

11/7/24 POSI

KGC reported for 9 months of 2024 by RAS

11/7/24 KGKC

PhosAgro sales for 9 months increased by 4.2%

11/7/24 PHOR

PhosAgro reports for 9 months of 2024 by IFRS

11/7/24 PHOR

Novatek will expand its network of cryo-filling stations

11/7/24 NVTK

Board of Directors of Phosagro recommended dividends

11/7/24 PHOR

Magnit will increase the area of warehouse complexes by 800 thousand sq. m.

11/7/24 MGNT

IVA Technologies has reported for 9 months of 2024 by RAS

11/7/24 IVAT

Abrau-Durso reported for 9 months of 2024 by RAS

11/7/24 ABRD

Positive Technologies shipments increased 2% in 9 months

11/7/24 POSI